Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation [0.03%]
头孢他啶-阿维巴坦与多黏菌素B治疗碳青霉烯耐药肠杆菌科感染的有效性、安全性和成本效益分析：目标试验模拟研究
Na Hu,Fengjiao Xiao,Yechao Chen et al.
Na Hu et al.
Introduction: Treatment options for carbapenem-resistant Enterobacteriaceae (CRE) infections are limited, with polymyxin B (PMB) and ceftazidime-avibactam (CZA) being among the available choices. However, research on thes...
Tackling CMV in Transplant Recipients: Past, Present, and Future [0.03%]
移植受者CMV感染的预防、诊断和治疗：过去、现在和未来
Tal Schlaeffer-Yosef,Lior Nesher
Tal Schlaeffer-Yosef
Cytomegalovirus (CMV), a beta-herpesvirus capable of maintaining lifelong latency, presents a substantial risk to transplant recipients, resulting in significant morbidity and mortality among both hematopoietic stem cell and solid organ tra...
Clinical Pharmacokinetics and Safety of a New HIV-1 Capsid Inhibitor, VH4004280, After Oral Administration in Adults Without HIV [0.03%]
新型HIV-1衣壳抑制剂VH4004280的I期临床药代动力学和安全性研究
Nilay Thakkar,Rulan Griesel,Amy Pierce et al.
Nilay Thakkar et al.
Introduction: The pharmacokinetics, drug-drug interaction potential, and safety of a new HIV-1 capsid inhibitor, VH4004280 (VH-280), are described in this first-time-in-human study. ...
Respiratory Syncytial Virus (RSV) as a Secondary Diagnosis among Hospitalized Patients in Germany: Outcomes and Economic Burden [0.03%]
德国住院患者中副流感病毒作为次要诊断的结果和经济负担
Markus Weinert,Jana Diekmannshemke,Kylie Braegelmann et al.
Markus Weinert et al.
Introduction: Respiratory syncytial virus (RSV) is a pathogen that may cause severe respiratory infections. Recent research indicates that RSV may be underdiagnosed, especially in adult populations. This study aims to inv...
Correction: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study [0.03%]
一项关于四价脑膜炎球菌结合疫苗相对于Nimenrix的免疫原性和安全性的健康青少年中的随机III期多中心研究的更正研究报告
Javier Díez-Domingo,Róbert Simkó,Giancarlo Icardi et al.
Javier Díez-Domingo et al.
Published Erratum
Infectious diseases and therapy. 2025 Apr 24. DOI:10.1007/s40121-025-01150-1 2025
A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract Infection [0.03%]
复杂尿路感染流行病学的系统文献回顾
Edward Broughton,Meryem Bektas,Ann Colosia et al.
Edward Broughton et al.
Introduction: Urinary tract infections (UTIs) are common bacterial infections and present with heterogeneous clinical phenotypes. Whereas many uncomplicated UTIs resolve spontaneously or with antibiotic treatment, a compl...
An Economic Model to Assess the Cost Impact of Using Xpert Carba-R to Screen Carbapenemase-Producing Enterobacterales in Comparison with Standard of Care, in a National Health Service Setting [0.03%]
在国家卫生服务背景下，评估Xpert Carba-R筛查产 carbapenem酶肠杆菌科细菌相对于标准护理的成本影响的经济模型
Mondher Toumi,Ruth Pulikottil-Jacob,Karina Watts et al.
Mondher Toumi et al.
Introduction: Carbapenemase-producing Enterobacterales (CPE) are bacteria that produce carbapenemases, enzymes that destroy carbapenem antibiotics and result in carbapenem resistance. Early identification of individuals w...
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study [0.03%]
恩司特雷韦单用或与奈玛特韦联用治疗奥密克戎变异株感染住院患者：一项单中心观察性研究
Masaya Yamato,Masahiro Kinoshita,Yuki Yoshida et al.
Masaya Yamato et al.
Introduction: Ensitrelvir, a novel oral 3C-like protease inhibitor targeting severe acute respiratory syndrome coronavirus 2, has been available in Japan since November 2022. This report presents patient characteristics a...
Predicting ICU Admission Risk in Children with Respiratory Syncytial Virus [0.03%]
预测呼吸道合胞病毒患儿入住重症监护病房的风险
Young Hwa Lee,Young June Choe,Yoon Sun Yoon et al.
Young Hwa Lee et al.
Introduction: Respiratory syncytial virus (RSV) is a common infection in young children and a frequent cause of hospitalization. In some cases, RSV can lead to severe lower respiratory tract illness requiring admission to...